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Bovine serum albumin (BSA) is currently recommended as an interfering substance to emulate organic
soiling, in evaluating the eﬃcacy of disinfectants. The European Standard recommends 0.03% BSA to test
clean conditions and 0.3% for dirty conditions. Reactive oxygen species are known to exert excellent
antimicrobial activity with low speciﬁcity against a broad range of pathogens. Herein, we present our
data from the ﬁrst study of the eﬀects of the addition of BSA on the antibacterial activity of light
activated antimicrobial surfaces. Light activated antimicrobial surfaces were made from polyurethane
swell-encapsulated with gold nanoparticles (AuNPs) coated with the light active triarylmethane dye,
crystal violet (PU-AuNP-CV). The antibacterial eﬃcacy of the antimicrobial substrates was tested against
two strains of Staphylococcus aureus 8325-4, a well-characterised laboratory strain and MRSA 4742,
a recent clinical isolate, in the presence of 0.1% to 1% BSA by irradiating the substrates with a ﬂuorescent
lamp (300 lux). After 6 hours of irradiation, the number of surviving bacteria was determined. The results
showed that BSA reduced the antibacterial eﬃcacy of all the PU-AuNP-CV surfaces with increasing BSA
concentrations resulting in a progressive reduction in antibacterial activity towards the bacteria tested.
However, the light activated surfaces did perform well at 0.1 and 0.25% BSA levels, showing they may
have potential for real world environments with low levels of organic soiling.Introduction
Hospital acquired infections (HAIs) present a considerable
challenge due to the ability of pathogens to spread within
healthcare environments and the increasing development of
drug resistance.1 One of the most common ways in which
bacteria are spread in hospital environments is through contact
between surfaces, patients and healthcare workers. A key issue
is that there are numerous touch surfaces within hospital
environments which can harbour and spread microorganisms,
including telephones, keyboards, furniture (bed rails and door
handles), food trays, and implanted medical equipment such as
catheters.2–4 Although established disinfection protocols may
help prevent the build-up of bacteria on surfaces, some bacteria
are able to resist disinfection and form potential reservoirs of
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58methicillin-sensitive Staphylococcus aureus (MSSA), Clostridium
diﬃcile and E. coli are of major importance in healthcare
associated infection. Their screening, monitoring and reporting
are mandatory for healthcare facilities.6 One of the main
concerns in the hospital environment is Staphylococcus aureus
that is part of the microbiota of 30% of the population but can
also be a dangerous pathogen that can cause bacteraemia and
pneumonia among other infections. It has been reported that
methicillin resistant strains of S. aureus can survive on surfaces
for as long as 360 days. Apart from cleaning and disinfection
there are not many eﬀective ways adequate to deal with this
organism.7,8 Escherichia coli (E. coli) is a Gram-negative bacte-
rium part of our gut microbiota. Gram-negative bacteria are of
great concern due to the prevalence of antibiotic resistant
strains.9 E. coli alone is the major cause of bloodstream infec-
tions in England and responsible for the majority of community
and hospital acquired infections. Among those are urinary tract
infections and food poisoning.10
There are many reports of antimicrobial surfaces for the
prevention or reduction of bacterial surface contamination.3,11,12
While most surfaces comprise either metal nanoparticles or
light activated antibacterial components, a minority employ
a combination of both. Our previous work has reported anti-
bacterial surfaces made from polyurethane swell-encapsulated
with gold nanoparticles (AuNPs), coated with a light active tri-
arylmethane dye, crystal violet (CV).13–15 When thiol-cappedThis journal is © The Royal Society of Chemistry 2018
Paper RSC Advances2 nm AuNPs are combined with photosensitised dyes (such as
CV), a synergy of antibacterial eﬃcacy is observed. We have
previously shown that this enhancement in bactericidal activity
is related to the size of the AuNPs, where 2 nm are the most
eﬀective at enhancing the antibacterial eﬀect.13 Other studies
using similar approaches using copper14 or zinc nano-
particles15,16 with light activated antimicrobial surfaces also
demonstrate the potential of antibacterial surfaces for use in
healthcare environments.
The antibacterial properties of light activated antimicrobial
materials have been reported against representative Gram-
positive and Gram-negative bacteria, and have shown on
average 3 log (99.9% kill) and 1.5 (95% kill) log reduction in
bacterial numbers, respectively.15–18 The activity of such mate-
rials can be ne-tuned by modifying the capping ligands in the
AuNPs, the nanoparticle concentration and by the use of
diﬀerent dyes or combination of dyes.13,16,17 The antibacterial
properties of such surfaces are activated by light, where during
irradiation, immobilised dye molecules (CV) are promoted to an
excited singlet state that can undergo inter-system crossing to
a triplet state. The excited dye molecule can participate in
a series of photochemical reactions that will lead to the gener-
ation of diﬀerent reactive oxygen species (ROS).19 ROS is a term
used to categorise an array of reactive molecules and free
radicals that are generated by the incomplete reduction of
oxygen. Such species are extremely reactive towards important
biomolecular substrates such as amino acid residues, which
can give rise to free radical oxidative chain reactions that are
toxic to bacteria.20–22 In such systems, these photochemical
reactions yield a range of diﬀerent reactive oxygen species
(ROS), including H2O2, via a type I or type II process.14,15,18
A study by Imlay and Linn23 with E. coli shows that at low
concentrations of H2O2 (1–3 mM) bacteria were killed mostly by
DNA damage. At higher concentrations the occurrence of more
generalised damage was evident, and there was also evidence
that the DNA damage was dependent on iron suggesting that,
through the Fenton reaction, hydroxyl radicals or other ferrous
products were taking part in the mechanism.23,24 Commonly,
higher antibacterial activity is observed against Gram-positive
bacteria compared to Gram-negative bacteria; the presence of
a thicker cell wall and defence mechanisms such as ROS scav-
engers can increase the tolerance of organisms to the damage
caused by ROS.25,26 One of the drawbacks of using ROS is their
extreme reactivity towards organic compounds such as
proteins, coupled with a short lifetime.27,28 In order to harness
the full power of ROS, somemanufacturers address this issue by
relying on the use of ROS precursors and H2O2 activators to
generate peracids and ROS in situ rather than including this in
their formulation.29–32 Despite this, ROS are extremely eﬀective
in the removal of dirt, disinfection and, are currently employed
in many situations including water treatment facilities, the
paper industry, health facilities, and household cleaners among
others.27,29,33,34
The European Standard EN 1276 “Chemical disinfectants
and antiseptics – quantitative suspension test for the evaluation
of bactericidal activity of chemical disinfectants and antiseptics
used in food, industrial, domestic and institutional areas”This journal is © The Royal Society of Chemistry 2018recommends the testing conditions acceptable in Europe to
determine the antibacterial activity of products released or to be
released for the “general public”. Its scope mainly refers to
liquid suspension testing with the use of pre-set conditions to
allow comparison between data generated in diﬀerent labora-
tories.35 The European Standard also considers the use of an
interfering substance that will mimic the impurities/
contamination present in the environment. For this purpose
it recommends the use of bovine serum albumin (BSA) in order
to mimic organic soiling.36 Serum albumin is the most abun-
dant protein in the circulatory system of animals and humans
possessing a wide range of functions such as, transport, free
radical scavenging and osmotic pressure regulation37,38 and
binding toxic substances.39 Furthermore, it is also recom-
mended for the product to be tested under simulated clean
(0.03% BSA) and dirty (0.3% BSA) conditions,35 thus making the
test more robust and a better model of real case scenarios.
In this paper light activated antimicrobial surfaces were
challenged with bacterial suspensions of a clinical isolate of
methicillin-resistant Staphylococcus aureus (MRSA) and a meth-
icillin sensitive strain of S. aureus, 8325-4 (ref. 40 and 41) (MSSA)
as representative Gram-positive bacterium, and a clinical isolate
of E. coli as a representative Gram-negative bacterium in the
presence of various concentrations of BSA. The antibacterial
eﬃcacy of the surfaces was determined aer irradiation by
determining the number of surviving bacteria. We show that at
low concentrations of BSA these surfaces work well (0–0.25%
BSA), they function adequately at 0.5% BSA showing between
95–99% kill but are inactivated at 1% BSA and above. The tests
were performed at low light intensities (300 lux) to simulate
hospital ward conditions.42Materials and methods
Materials chemistry characterisation
Transmission Electron Microscopy (TEM) was performed using
a JEOL 2010 TEM operating at 200 kV. Image collection and
processing was performed on a CCD with Gatan Digital Micro-
graph soware. Particle size analysis was carried out using
ImageJ soware. X-ray photoelectron spectroscopy (XPS) was
carried out using a Thermo Scientic K-alpha photoelectron
spectrometer with monochromatic Al-Ka radiation to analyse
the Au nanostructures in polyurethane. Peak positions were
calibrated to carbon (285 eV) and plotted using the CasaXPS and
qtiplot soware.Synthesis of thiol-capped 2 nm AuNPs
AuNPs were synthesised according to a method previously
described by Brust et al.43 Briey, a 6 mL (30 mM) aqueous
solution of chloroauric acid trihydrate (VWR, UK) was mixed
with 16 mL (50 mM) tetraoctylammonium bromide (Sigma
Aldrich, UK) in toluene. Once the gold salt was transferred to
the organic phase, 40 mL (10.5 mM) of 1-dodecanethiol (Sigma
Aldrich, UK) was added as a capping ligand. A solution of freshly
prepared 5 mL (0.4 mM) sodium borohydride was added
dropwise to the mixture, and the solution was le to stir for 3RSC Adv., 2018, 8, 34252–34258 | 34253
RSC Advances Paperhours. The organic layer was extracted and the AuNP solution
was concentrated on a rotary evaporator (2 mL). 40 mL of
ethanol (Sigma Aldrich, UK) was added to the concentrate and
the AuNPs were stored for 4 hours at18 C, aer which a black
precipitate was formed. The AuNPs were centrifuged and
concentrated to yield 1 mg mL1 in toluene (Sigma Aldrich,
UK) before further use.
Polyurethane nanoparticle swell-encapsulation
The method used was adapted from the work of Noimark et al.
(2015)15 and Sehmi et al. (2016)17 using the following: medical
grade polyurethane (Branford, CT, USA), toluene analytical
reagent grade (Fisher Chemical), crystal violet (CV) (Sigma-
Aldrich).
First 1  1 cm polyurethane (PU) squares were immersed in
a 1 mg mL1 AuNP solution (synthesis described above) in
toluene for 24 hours to swell-encapsulate. Then the squares
were air dried on a clean glass surface for approximately 12
hours.
The polyurethane squares were then immersed in a 0.0001 M
crystal violet solution for 72 hours, in the dark. The solution was
gently stirred twice a day to circulate the dye between polymers
and the samples were rinsed in deionised H2O and air dried in
the dark for 24 hours.
A set of control polymers was also prepared using only the
swell-encapsulation solvent (toluene).
Antibacterial testing
The antibacterial testing was carried out as previously
described15,17 with the addition of various concentrations of
bovine serum albumin (BSA) (Sigma) to phosphate-buﬀered
saline (PBS, Oxoid). Two strains of S. aureus were used: a clin-
ical methicillin-resistant strain (MRSA 4742; obtained from P.
Wilson, University College London Hospital), and S. aureus
8325-4 (ref. 40 and 41) and E. coli 1030, a multidrug resistantFig. 1 (a) TEM image of the AuNPs and the inset shows the particle size h
of 0.21 nm consistent with the {111} plane.
34254 | RSC Adv., 2018, 8, 34252–34258strain positive for both NDM and OXA-48-like carbapenemase
genes (obtained from J. Wade, King's College Hospital, Lon-
don). The strains were stored at70 C in BHI broth containing
20% (v/v) glycerol and propagated on mannitol salt agar (Oxoid)
or MacConkey agar (Oxoid) for a maximum of two subcultures
every two weeks.
The bactericidal properties of 1  1 cm PU squares (control
and CV + AuNP) were tested against MRSA 4742, S. aureus 8325-4
and E. coli 1030. The inoculum was prepared by inoculating
10 mL BHI with a single colony and incubating for 18 hours
(200 rpm, 37 C). The bacteria were collected by centrifugation
(20 C, 4500g, 5 min) and washed twice using PBS and resus-
pended in 10 mL of PBS. The suspensions were then diluted
1000-fold into PBS with the desired concentration of BSA (5%,
2%, 1%, 0.5%, 0%) to attain an inoculum of 105–106 colony
forming units (CFU) per mL. In each experiment the inoculum
was conrmed by plating serial dilutions on agar in duplicate
for viable counts. The test materials (PU + CV and PU + AuNP +
CV) were inoculated with 25 mL of the inoculum containing
105–106 CFU mL1, placed inside a Petri dish and irradiated
using a conventional ceiling uorescent lamp with an average
intensity of 300 lux for a 6 hours period for the gram positives
and 48 hours for the gram negatives. Aer irradiation, the
inoculated samples were added to 450 mL PBS and vortexed to
remove all the bacteria. Aerwards the resulting neat suspen-
sion and serial dilutions were plated on Columbia agar
enriched with 5% horse blood and incubated for 24 hours
(37 C, 5% CO2) to determine the viable counts.Results and discussion
AuNPs were synthesised as described in the materials and
Methods section,13,43 and their particle size was characterised
using transmission electron microscopy (TEM). Fig. 1 shows the
TEM and a particle size distribution of the AuNPs revealing theiristogram. (b) high resolution-TEM of the AuNPs showing lattice spacing
This journal is © The Royal Society of Chemistry 2018
Paper RSC Advancessize of 2.2  0.5 nm, which corresponds to previously reported
methods.13 High-resolution TEM shows the AuNPs have a lattice
spacing of 0.21 nm which is very close to the {111} plane.44 The
polyurethane squares were swell-encapsulated using a 1 mg
mL1 AuNP solution in toluene for 24 hours and subsequently
coated with CV in solution 0.001 M. Aer rinsing to remove
excess CV, the polymer squares looked uniformly dark blue
without any deposits or abnormal features on its surface. Prior to
the antimicrobial testing, the polymers were carefully checked,
visually, for any imperfections. The presence of AuNPs in poly-
urethane has been well characterised in our previous reports,13
however X-ray photoelectron spectroscopy (XPS) was also used in
this work to conrm the presence of AuNPs in the polymer. In
order to conrm that the AuNPs were not simply deposited on the
surface of the polymer, a monatomic depth prole was
measured. This involved using a calibrated ion beam that etched
layers oﬀ the polymer, revealing subsurface information. The
etching was performed for 200 seconds which corresponded to
a penetration of 50 nm as per our previous report.13 Fig. 1S†
veried the Au4f(5/2) and Au4f(7/2) peaks at 87.3 eV and 83.6 eV
respectively. The AuNP peaks present in the Au4f spectra corre-
spond to a spin orbital splitting of 3.7 eV. The Au4f(7/2) peak at
83.6 eV is closely matched with that of metal Au0 which is typi-
cally present at 84.0 eV. The slight negative shi of 0.4 eV for Au0
can be due to the interaction of the organic capping ligands with
the polyurethane surface.45,46Fig. 2 The numbers of S. aureus 8325-4 CFU recovered after irradiation a
(PU); PU + AuNP + CV – PU with encapsulated AuNP and coated with cr
three times. The data shows mean values + SD, statistical signiﬁcance wa
to its respective control (*p < 0.001).
This journal is © The Royal Society of Chemistry 2018For S. aureus 8325-4 (Fig. 2), in the absence of BSA, a 3.8 log
reduction in bacterial numbers (99.9%) was obtained aer 6
hours exposure to 300 lux irradiation. In the presence of either
0.1% or 0.25% BSA, the reduction in bacterial numbers was
2.1 log (99%) and only 1.5 log in the presence of 0.5% BSA. At
1% BSA, only a 0.5 log reduction in bacterial numbers was
observed. This result shows that, as expected, by increasing the
protein load within our test, we reduce the antibacterial eﬃcacy
of the material but importantly, some activity is retained under
low soiling conditions.
For EMRSA4742, the inhibitory eﬀect of BSA towards ROS-
induced kill was more evident as shown in Fig. 3 and 5. In the
absence of BSA, a log reduction of 3.7 in the number of bacteria
was observed and a reduction in the bactericidal activity was
again apparent in the presence of BSA. At a concentration of
0.1% BSA, PU + AuNP + CV showed a 1.5 log reduction in
bacterial numbers and the bactericidal activity was gradually
reduced with increasing BSA concentration: a 0.4 log reduction
in bacterial numbers at 0.25% BSA compared to a 0.1 log
reduction in the presence of 0.5% BSA.
For E. coli 1030, a 1 log reduction in bacterial numbers was
observed in the absence of BSA and a statistically signicant
reduction in bacterial numbers was only apparent at
concentrations of 0.1% BSA and below, as shown in
Fig. 4 and 5.t 300 lux, 6 hours. Initial – inoculum; control– untreated polyurethane
ystal violet. All experiments were carried out in duplicate and repeated
s determined using the Student's t-test comparing each test condition
RSC Adv., 2018, 8, 34252–34258 | 34255
Fig. 3 The numbers of EMRSA-4742 recovered after irradiation 300 lux, for 6 hours. Initial – inoculum; control – untreated polyurethane (PU);
PU + AuNP + CV – PU with encapsulated AuNP and coated with crystal violet. All experiments were carried out in duplicate and repeated three
times. The data shows mean values + SD, statistical signiﬁcance was determined using the Student's t-test comparing each test condition to its
respective control (*p < 0.005, **p ¼ 0.001, ***p ¼ 0.01).
Fig. 4 The numbers of E. coli 1030 recovered after irradiation 300 lux, for 48 hours. Initial – inoculum; control – untreated polyurethane (PU);
PU + AuNP + CV – PU with encapsulated AuNP and coated with crystal violet. All experiments were carried out in duplicate and repeated three
times. The data shows mean values + SD, statistical signiﬁcance was determined using the Student's t-test comparing each test condition to its
respective control (*p < 0.05).
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Fig. 5 log10 reduction of EMRSA 4742, S. aureus 8325-4 and E. coli
1030 observed after irradiation 300 lux, 6 hours for S. aureus 8325-4
and MRSA 4742. With the addition of BSA these reductions are
decreased diﬀerently between each tested organism. The data in the
graph shows mean values + the bars show the SD.
Paper RSC AdvancesSerum albumin can bind to a wide range of molecules and
some of its antioxidant properties arise from the binding and
inactivation of oxidative molecules.39,47
It is interesting that in the absence of BSA, the two strains of
S. aureus showed similar susceptibility to the nanoparticles
whereas in the presence of 0.25% BSA and above, the clinical
EMRSA strain was signicantly more resistant. The reason for
this diﬀerence requires further investigation.
Previous studies13 using thiol capped AuNP encapsulated in
polyurethane and also coated in CV showed excellent antibac-
terial activity towards S. aureus and E. coli demonstrating an
approximately 6 log reduction in the bacterial numbers for both
organisms within 2 hours for S. aureus and 6 hours for E. coli.
This higher antimicrobial activity can be attributed to the fact
that 6000 lux were used as irradiation energy.
An important and novel aspect of the work reported here is
that we used 300 lux which is equivalent to ambient light in
a hospital ward and 20 times less intense than our previous
reports.4,13,14,16 Obviously the antimicrobial properties of the
surfaces would be more eﬀective at higher light intensities.13
For example, normal day-light ranges between 1000–10 000 lux.
Therefore, the antimicrobial eﬃcacy of such materials will be
increased under natural light conditions.Conclusions
Polyurethane swell encapsulated with gold nanoparticles coated
with crystal violet (PU-AuNP-CV) substrates showed a signicant
level of light-induced antibacterial activity against the tested
organisms. Under a low visible light intensity of 300 lux, the
substrates showed log reductions of 3.7 and 3.8 for EMRSA-4742
and S. aureus 8325-4 respectively that correlates with the elim-
ination of 99.99% of the inoculated bacteria aer exposure to
300 lux light intensity for 6 hours. In the case of E. coli 1030 only
1 log reduction was observed aer 48 hours irradiation with 300
lux. It is well known that Gram-negative bacteria are more
resilient to ROS presumably as a result of reduced penetration
across the double membrane comprising its cell wall. LightThis journal is © The Royal Society of Chemistry 2018alone in the absence of CV and/or AuNPs induced negligible
kill.
Furthermore, we conducted a systematic study of the eﬀect
of adding BSA at diﬀerent concentrations and demonstrated
that its addition impaired the antibacterial eﬃcacy of our
material which is attributed to the antioxidant properties of BSA
which scavenges the ROS released at the polymer surface.
Importantly, the data presented shows that these materials
retain some activity even in the presence of low soiling and at
low light levels.
In conclusion, we nd that light-activated antimicrobial
surfaces are eﬀective and show statistically signicant bacteri-
cidal activity at low levels of light illumination (300 lux) under
both European Standard clean (0.03% BSA > 99% kill) and dirty
(0.3% BSA > 99% kill) conditions, against the Gram-positive
bacteria tested. Under extremely soiled conditions, three-fold
higher than the European Standard recommendation, they are
still functional, retaining approximately 50% activity.
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